0000001 001  NULL    **6;0;START              
0000001 002  -----   -----                    
0000004 010  AT1     A                        Z5 
0000004 020  JJ      natural                  A6.2+ A9+ A5.4+ W3 W5 B1 K2 
0000004 030  NN1     protein                  O1 
0000004 040  VVN     produced                 A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000004 050  II      in                       Z5 
0000004 060  AT      the                      Z5 
0000004 070  NN1     milk                     F2 O1.2 
0000004 080  IO      of                       Z5 
0000004 090  NN1     GEM                      O1.1 O4.2+ O4.2+/S2mf X4.1 
0000004 100  CC      and                      S2mf[i1.2.1 Z5 
0000004 110  JJ      other                    S2mf[i1.2.2 A6.1- 
0000004 120  JJ      transgenic               Z99 
0000004 130  NN2     cows                     L2fn S2.1f/O4.2- 
0000004 140  VVZ     kills                    L1- A12- A1.5.1 E4.1-/A2.2 
0000004 150  AT      the                      Z5 
0000004 160  NN2     bacteria                 L2c 
0000004 170  CST     that                     Z8 Z5 
0000004 180  VV0     cause                    A2.2 
0000004 190  NN1     mastitis                 Z99 
0000004 191  .       .                        
0000005 001  -----   -----                    
0000006 010  NP1     WASHINGTON               Z2 Z1mf 
0000006 011  ,       ,                        
0000006 020  NPM1    April                    T1.3 
0000006 030  NP1     4--U.S                   Z99 
0000006 031  .       .                        
0000006 032  -----   -----                    
0000006 040  NN1     Department               H2/S5+c X2.2 
0000006 050  IO      of                       Z5 
0000006 060  NN1     Agriculture              F4 
0000006 070  NN2     researchers              X2.4/S2mf 
0000006 080  VH0     have                     Z5 A9+ A2.2 S4 
0000006 090  VVN     used                     A1.5.1 S7.1+ 
0000006 100  JJ      gene-transfer            Z99 
0000006 110  NN2     technologies             Y1 
0000006 120  TO      to                       Z5 
0000006 130  VVI     produce                  A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000006 140  NN1     dairy                    F4/L2[i2.2.1 F4 
0000006 150  NN2     cows                     F4/L2[i2.2.2 L2fn S2.1f/O4.2- 
0000006 160  CST     that                     Z8 Z5 
0000006 170  VV0     resist                   S8- 
0000006 180  AT1     a                        Z5 
0000006 190  JJ      widespread               N5.1+ N3.6+/A2.1 
0000006 200  JJ      bacterial                L2 
0000006 210  NN1     infection                B2- 
0000006 220  VVN     called                   Q2.2 S1.1.1 Q1.3 S9% 
0000006 230  NN1     mastitis                 Z99 
0000006 231  .       .                        
0000008 001  NULL    <quote>                  
0000008 002  -----   -----                    
0000008 003  "       "                        
0000008 010  DD1     This                     M6 Z5 Z8 
0000008 020  NN1     research                 X2.4 
0000008 030  VBZ     is                       A3+ Z5 
0000008 040  AT1     an                       Z5 
0000008 050  JJ      important                A11.1+ 
0000008 060  MD      first                    N4 
0000008 070  NN1     step                     M1 T1.2 H5 O2 A2.1+ A1.1.1 K1@ K5.1@ 
0000008 080  II      in                       Z5 
0000008 090  VVG     understanding            X2.5+ 
0000008 100  RRQ     how                      Z5 A13.3 
0000008 110  NN2     genes                    B1 
0000008 120  VM      can                      A7+ 
0000008 130  VBI     be                       Z5 A3+ 
0000008 140  VVN     used                     T1.1.1[i3.2.1 A6.2+[i3.2.1 A1.5.1 S7.1+ 
0000008 150  TO      to                       T1.1.1[i3.2.2 A6.2+[i3.2.2 Z5 
0000008 160  VVI     protect                  S8+/A15+ A10- 
0000008 170  NN2     animals                  L2mfn S5+c O2c 
0000008 180  II      from                     Z5 
0000008 190  NN1     disease                  B2- 
0000008 191  ,       ,                        
0000008 192  "       "                        
0000008 193  NULL    </quote>                 
0000008 194  -----   -----                    
0000008 200  VVD     said                     Q2.1 
0000008 210  NP1     Edward                   Z1mf[i5.3.1 Z3c[i5.3.1 Z1m Z1mf[i4.2.1 Z3c[i4.2.1 
0000008 220  NP1     B.                       Z1mf[i5.3.2 Z3c[i5.3.2 Z1mf[i4.2.2 Z3c[i4.2.2 Z1mf[i6.2.1 Z3c[i6.2.1 
0000008 230  NP1     Knipling                 Z3c[i5.3.3 Z1mf[i5.3.3 Z1mf[i6.2.2 Z3c[i6.2.2 
0000008 231  ,       ,                        
0000008 240  NN1     administrator            S7.1+/S2mf 
0000008 250  IO      of                       Z5 
0000008 260  NP1     USDA                     Z99 
0000008 261  GE      's                       Z5 
0000008 270  JJ      Agricultural             F4 
0000008 280  NN1     Research                 X2.4 
0000008 290  NN1     Service                  S8+ S7.1- I2.2 A1.1.1 S9 I3.1 F1 G3@ G1.1@ G2.1@ 
0000008 291  (       (                        
0000008 300  NP2     ARS                      Z4 
0000008 301  )       )                        
0000008 302  .       .                        
0000009 001  -----   -----                    
0000010 010  DD1     This                     M6 Z5 Z8 
0000010 020  JJ      scientific               Y1 
0000010 030  NN1     discovery                A10+ 
0000010 031  ,       ,                        
0000010 040  VVN     published                Q4 
0000010 050  II      in                       Z5 
0000010 060  AT      the                      Z5 
0000010 070  JJ      current                  T1.1.2 
0000010 080  NN1     edition                  Q4 
0000010 090  IO      of                       Z5 
0000010 100  NN1     Nature                   W5 A4.1 S1.2 A6.2+ 
0000010 110  NN1     Biotechnology            Y1/L1 Y1/B3 
0000010 111  ,       ,                        
0000010 120  VVZ     demonstrates             A10+ G1.2 
0000010 130  AT      the                      Z5 
0000010 140  NN1     potential                A7+ O3 
0000010 150  IO      of                       Z5 
0000010 160  NN1     biotechnology            Y1/L1 Y1/B3 
0000010 170  IF      for                      Z5 
0000010 180  JJ      developing               A2.1+ T2+ A5.1+/A2.1 N3.2+/A2.1 H1 A9+ C1 
0000010 190  NN2     cattle                   L2mfn 
0000010 200  IW      with                     Z5 
0000010 210  NN1     resistance               S8- S1.2.5+ 
0000010 220  II      to                       Z5 
0000010 230  NN1     mastitis                 Z99 
0000010 231  .       .                        
0000010 232  -----   -----                    
0000010 240  RR      Currently                T1.1.2 
0000010 241  ,       ,                        
0000010 250  NN2     vaccines                 B3 
0000010 251  ,       ,                        
0000010 260  NN2     antibiotics              B3 
0000010 270  CC      and                      Z5 
0000010 280  AT1     a                        Z5 
0000010 290  NN1     cow                      L2fn S2.1f/O4.2- 
0000010 291  GE      's                       Z5 
0000010 300  DA      own                      A9+ S5- 
0000010 310  JJ      immune                   B1[i7.2.1 B2+ B1 A2.2- A1.9 
0000010 320  NN1     system                   B1[i7.2.2 X4.2 O3 M3 M4 Q1.3 Y2 B1 N2 G1.1c 
0000010 330  VM      can                      A7+ 
0000010 331  XX      not                      Z6 
0000010 340  RR      effectively              A5.4+ X9.2+ 
0000010 350  VVI     fight                    S8- X8+ E3- G1.2 
0000010 360  AT      the                      Z5 
0000010 370  NN1     bacterium                L2 
0000010 380  NN1     Staphylococcus           Z99 
0000010 390  NN      aureus                   Z99 
0000010 391  ,       ,                        
0000010 400  AT1     a                        Z5 
0000010 410  JJ      major                    A11.1+ N3.2+ 
0000010 420  NN1     cause                    A2.2 X2.1 X4.1 
0000010 430  IO      of                       Z5 
0000010 440  NN1     mastitis                 Z99 
0000010 441  .       .                        
0000011 001  -----   -----                    
0000012 010  AT1     A                        Z5 
0000012 020  JJ      scientific               Y1 
0000012 030  NN1     team                     S5+c K5.1/S5+c S5+ 
0000012 040  VVN     led                      S7.1+ A2.2 M2 A1.1.1 
0000012 050  II      by                       Z5 
0000012 060  NP1     Robert                   Z1mf[i9.3.1 Z3c[i9.3.1 Z1m Z1mf[i8.2.1 Z3c[i8.2.1 
0000012 070  NP1     J.                       Z1mf[i9.3.2 Z3c[i9.3.2 Z1mf[i8.2.2 Z3c[i8.2.2 Z1mf[i10.2.1 Z3c[i10.2.1 
0000012 080  NP1@    Wall                     Z3c[i9.3.3 Z1mf[i9.3.3 Z1mf[i10.2.2 Z3c[i10.2.2 
0000012 081  ,       ,                        
0000012 090  AT1     an                       Z5 
0000012 100  NN1     animal                   L2mfn S5+c O2c 
0000012 110  NN1     physiologist             Z99 
0000012 120  IW      with                     Z5 
0000012 130  AT      the                      Z5 
0000012 140  NP2     ARS                      Z4 
0000012 150  NN1     Biotechnology            Y1/L1 Y1/B3 
0000012 160  CC      and                      Z5 
0000012 170  NP1     Germplasm                Z99 
0000012 180  NN1     Laboratory               Y1/H1c 
0000012 190  II      in                       Z5 
0000012 200  NP1     Beltsville               Z99 
0000012 201  ,       ,                        
0000012 210  NNA     Md.                      S7.1+/S2mf B3/S2mf B3/P1 
0000012 211  ,       ,                        
0000012 220  VVD     built                    H1 A1.1.1 A5.1+/A2.1 N3.2+/A2.1 
0000012 230  AT1     a                        Z5 
0000012 240  JJ      transgene--genetic       Z99 
0000012 250  NN1     material                 O1 B5 O2 X2.2 S1.2 
0000012 260  VVD     produced                 A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000012 270  VVG     using                    A1.5.1 S7.1+ 
0000012 280  JJ      recombinant              Z99 
0000012 290  NN1     DNA                      B1 
0000012 300  CST     technology--that         Z8 
0000012 310  VVZ     includes                 A1.8+ 
0000012 320  AT      the                      Z5 
0000012 330  JJ      genetic                  Y1[i11.2.1 B1 
0000012 340  NN1     code                     Y1[i11.2.2 G2.1 A10-/Q1.1 G2.2 A4.1 Y2@ B3% B1% 
0000012 350  IF      for                      Z5 
0000012 360  VVG     producing                A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000012 370  AT1     a                        Z5 
0000012 380  RR      naturally                A6.2+ Z4 W5 A12+ X9.1+ 
0000012 390  VVG     occurring                A2.1+ A3+ X2.1 
0000012 391  ,       ,                        
0000012 400  JJ      antimicrobial            Z99 
0000012 410  NN1     protein                  O1 
0000012 420  VVN     called                   Q2.2 S1.1.1 Q1.3 S9% 
0000012 430  NN1     lysostaphin              Z99 
0000012 431  .       .                        
0000013 001  -----   -----                    
0000014 010  CS      While                    Z5 
0000014 020  DB      all                      N5.1+ 
0000014 030  NN1     milk                     F2 O1.2 
0000014 040  VVZ     contains                 A1.8+ A1.7+ 
0000014 050  DA2     several                  N5 
0000014 060  RR      naturally                A6.2+ Z4 W5 A12+ X9.1+ 
0000014 070  VVG     occurring                A2.1+ A3+ X2.1 
0000014 080  JJ      antimicrobial            Z99 
0000014 090  NN2     proteins                 O1 
0000014 091  ,       ,                        
0000014 100  II21    such                     Z5[i12.2.1 
0000014 110  II22    as                       Z5[i12.2.2 Z5 
0000014 120  NN1     lysozyme                 Z99 
0000014 130  CC      and                      Z5 
0000014 140  NN1     lactoferrin              Z99 
0000014 141  ,       ,                        
0000014 150  PN      none                     Z6/Z8c 
0000014 160  IO      of                       Z5 
0000014 170  AT      the                      Z5 
0000014 180  NN1     milk                     F2 O1.2 
0000014 190  VVN     produced                 A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000014 200  II      by                       Z5 
0000014 210  AT      the                      Z5 
0000014 220  MC      three                    N1 T1.2 T3 
0000014 230  NN2     cows                     L2fn S2.1f/O4.2- 
0000014 240  II      in                       Z5 
0000014 250  DD1     this                     M6 Z5 Z8 
0000014 260  NN1     research                 X2.4 
0000014 270  NN1     effort                   X8+ O2 
0000014 280  VM      will                     T1.1.3 
0000014 290  VBI     be                       Z5 A3+ 
0000014 300  VVN     consumed                 A1.5.1 F1 
0000014 301  .       .                        
0000014 302  -----   -----                    
0000014 310  NN1     Use                      A1.5.1 
0000014 320  IO      of                       Z5 
0000014 330  NN1     milk                     F2 O1.2 
0000014 340  VVG     containing               A1.8+ A1.7+ 
0000014 350  NN1     lysostaphin              Z99 
0000014 360  VM      would                    A7+ 
0000014 370  VVI     require                  X7+ S6+ 
0000014 380  JJ      federal                  S5+ 
0000014 390  JJ      regulatory               A1.7-/G1.1 
0000014 400  NN1     approval                 S7.4+ E2+ G1.1 
0000014 410  II      after                    Z5 
0000014 420  JJ      rigorous                 A1.7+ A4.2+ 
0000014 430  NN1     food                     F1 
0000014 440  NN1     safety                   A15+ 
0000014 450  NN1     testing                  P1 B3 X2.4 A12- 
0000014 451  .       .                        
0000014 452  -----   -----                    
0000014 460  DD1     This                     M6 Z5 Z8 
0000014 470  NN1     effort                   X8+ O2 
0000014 480  VBZ     is                       A3+ Z5 
0000014 490  II      at                       Z5 
0000014 500  AT      the                      Z5 
0000014 510  JJ      early                    T4+ T1.1.1 
0000014 520  NN2     stages                   T1.2 N5.1- H2/K4 K4 A4.1 
0000014 530  IO      of                       Z5 
0000014 540  NN1     research                 X2.4[i13.3.1 X2.4 
0000014 550  CC      and                      X2.4[i13.3.2 Z5 
0000014 560  NN1     development              X2.4[i13.3.3 A2.1+ A5.1+/A2.1 H1 
0000014 561  .       .                        
0000015 001  -----   -----                    
0000016 010  AT      The                      Z5 
0000016 020  NN1     research                 X2.4 
0000016 030  VVZ     shows                    A10+ S1.1.1 
0000016 040  CST     that                     Z5 Z8 
0000016 050  AT      the                      Z5 
0000016 060  NN1     gene                     B1 
0000016 070  IF      for                      Z5 
0000016 080  VVG     secreting                B1 A10- 
0000016 090  NN1     lysostaphin              Z99 
0000016 100  VVZ     comes                    M6[i14.2.1 A2.2[i14.2.1 M1 N3.1 A2.2 A3+ X2.1 A9+ S4 N4 S3.2 
0000016 110  II      from                     M6[i14.2.2 A2.2[i14.2.2 Z5 
0000016 120  AT1     a                        Z5 
0000016 130  JJ      non-pathogenic           Z99 
0000016 140  NN      species                  A4.1c L2c 
0000016 150  IO      of                       Z5 
0000016 160  NN1     Staphylococcus           Z99 
0000016 170  CST     that                     Z8 Z5 
0000016 180  VVZ     uses                     A1.5.1 S7.1+ 
0000016 190  AT      the                      Z5 
0000016 200  NN1     protein                  O1 
0000016 210  TO      to                       Z5 
0000016 220  VVI     repel                    G3 E2- 
0000016 230  APPGE   its                      Z8 
0000016 240  NN1     cousin                   S4mf 
0000016 241  ,       ,                        
0000016 250  NP1     S.                       T1.3 I1.1 Z5 
0000016 260  NN      aureus                   Z99 
0000016 261  .       .                        
0000016 262  -----   -----                    
0000016 270  AT      The                      Z5 
0000016 280  NN2     scientists               Y1/S2mf 
0000016 290  VVD     introduced               S1.1.1 T2+ 
0000016 300  DD1     this                     M6 Z5 Z8 
0000016 310  NN1     transgene                Z99 
0000016 320  II      into                     Z5 
0000016 330  NP1     Jersey                   Z2 
0000016 340  NN2     cows                     L2fn S2.1f/O4.2- 
0000016 341  .       .                        
0000016 342  -----   -----                    
0000016 350  AT      The                      Z5 
0000016 360  NN1     lysostaphin              Z99 
0000016 370  VBZ     is                       Z5 A3+ 
0000016 380  VVN     secreted                 B1 A10- 
0000016 390  II      into                     Z5 
0000016 400  NN1     milk                     F2 O1.2 
0000016 401  ,       ,                        
0000016 410  CS      where                    M6 
0000016 420  PPH1    it                       Z8 
0000016 430  VVZ     kills                    L1- A12- A1.5.1 E4.1-/A2.2 
0000016 440  NP1     S.                       T1.3 I1.1 Z5 
0000016 450  NN      aureus                   Z99 
0000016 451  ,       ,                        
0000016 460  RR      thus                     Z5/A2.2 
0000016 470  VVG     protecting               S8+/A15+ A10- 
0000016 480  NN2     cows                     L2fn S2.1f/O4.2- 
0000016 490  II      from                     Z5 
0000016 500  VVG     becoming                 A2.1+ O4.2+ 
0000016 510  JJ      infected                 B2- 
0000016 511  .       .                        
0000018 001  NULL    <quote>                  
0000018 002  -----   -----                    
0000018 003  "       "                        
0000018 010  AT      The                      Z5 
0000018 020  MC      three                    N1 T1.2 T3 
0000018 030  RR      genetically              B1 
0000018 040  JJ      engineered               S7.1+ A1.1.1 
0000018 050  NN2     cows                     L2fn S2.1f/O4.2- 
0000018 060  CST     that                     Z8 Z5 
0000018 070  VH0     have                     Z5 A9+ A2.2 S4 
0000018 080  VBN     been                     Z5 A3+ 
0000018 090  VVN     tested                   P1 B3 X2.4 A12- 
0000018 100  RG      so                       T1.1.2[i15.2.1 M6[i15.2.1 N5[i15.2.1 A13.3 
0000018 110  RR      far                      T1.1.2[i15.2.2 M6[i15.2.2 N5[i15.2.2 A13.3 N3.3+ X9.2+ 
0000018 120  VBR     are                      Z5 A3+ 
0000018 130  VVG     expressing               Q1.1 B1% 
0000018 140  NN1     lysostaphin              Z99 
0000018 150  II      in                       Z5 
0000018 160  APPGE   their                    Z8 
0000018 170  NN1     milk                     F2 O1.2 
0000018 180  CC      and                      Z5 
0000018 190  VBR     are                      A3+ Z5 
0000018 200  JJ      resistant                S8- O4.1 
0000018 210  II      to                       Z5 
0000018 220  NP1     S.                       T1.3 I1.1 Z5 
0000018 230  NN      aureus                   Z99 
0000018 240  JJ      intramammary             Z99 
0000018 250  NN1     infection                B2- 
0000018 251  ,       ,                        
0000018 252  "       "                        
0000018 253  NULL    </quote>                 
0000018 254  -----   -----                    
0000018 260  JJ%     said                     Q1.1 Q2.1 
0000018 270  NN1     Wall                     H2 O2 N5+ S8- 
0000018 271  .       .                        
0000018 272  NULL    <quote>                  
0000018 273  -----   -----                    
0000018 280  DB      All                      N5.1+ 
0000018 290  MC      three                    N1 T1.2 T3 
0000018 300  JJ      transgenic               Z99 
0000018 310  NN2     cows                     L2fn S2.1f/O4.2- 
0000018 320  VVD     showed                   A10+ S1.1.1 
0000018 330  JJ      little                   N3.2- T3- N3.7- N3.3- T1.3- A11.1- 
0000018 340  CC      or                       Z5 
0000018 350  AT      no                       A11.2-[i16.3.1 Z6 
0000018 360  NN1     sign                     A11.2-[i16.3.2 Q1.1 A6.2+ X4.1 Q1.2 O4.1 S9 B2 M2 K2 
0000018 370  IO      of                       A11.2-[i16.3.3 Z5 
0000018 380  NN1     infection                B2- 
0000018 390  II      after                    Z5 
0000018 400  JJ@     repeated                 N6+ 
0000018 410  NN2     exposures                A15- A10+ Q4 C1 
0000018 420  II      to                       Z5 
0000018 430  NP1     S.                       T1.3 I1.1 Z5 
0000018 440  CC      aureus--and              Z99 
0000018 450  PN1     one                      Z8 
0000018 451  ,       ,                        
0000018 460  VVD     named                    Q2.2 
0000018 470  NN1     GEM                      O1.1 O4.2+ O4.2+/S2mf X4.1 
0000018 471  ,       ,                        
0000018 480  RR      never                    T1/Z6 
0000018 490  VVD     became                   A2.1+ O4.2+ 
0000018 500  JJ      infected                 B2- 
0000018 501  ,       ,                        
0000018 510  VVG     indicating               A10+ M6 Q1.1/M3 
0000018 520  JJ      complete                 N5.1+ T2- N3.2+ 
0000018 530  NN1     protection               S8+/A15+ A10- 
0000018 531  .       .                        
0000018 532  "       "                        
0000018 533  NULL    </quote>                 
0000018 534  -----   -----                    
0000020 010  RR      Overall                  A14 
0000020 011  ,       ,                        
0000020 020  AT      the                      Z5 
0000020 030  NN2     researchers              X2.4/S2mf 
0000020 040  VVD     found                    A10+ X2.1 X6+ 
0000020 050  CST     that                     Z8 Z5 
0000020 060  II      in                       Z5 
0000020 070  NN2     tests                    P1 B3 X2.4 K5.1@ 
0000020 071  ,       ,                        
0000020 080  MC      71                       N5[i17.2.1 N1 T1.2 T3 T1.3 N3.2 
0000020 090  NNU     percent                  N5[i17.2.2 N5 
0000020 100  IO      of                       Z5 
0000020 110  AT      the                      Z5 
0000020 120  JJ      mammary                  Z99 
0000020 130  NN2     glands                   B1 
0000020 140  CST     that                     Z8 Z5 
0000020 150  VBDR    were                     Z5 A3+ 
0000020 160  VVN     exposed                  A10+ A15- G2.2-/S3.2 
0000020 170  II      to                       Z5 
0000020 180  NP1     S.                       T1.3 I1.1 Z5 
0000020 190  NN      aureus                   Z99 
0000020 200  II      from                     Z5 
0000020 210  JJ      nontransgenic            Z99 
0000020 220  NN2     animals                  L2mfn S5+c O2c 
0000020 230  VVD     became                   A2.1+ O4.2+ 
0000020 240  NN1     infected--compared       Z99 
0000020 250  II      to                       Z5 
0000020 260  RR      only                     A14 
0000020 270  MC      14                       N5[i18.2.1 N1 T1.2 T3 T1.3 N3.2 
0000020 280  NNU     percent                  N5[i18.2.2 N5 
0000020 290  IF      for                      Z5 
0000020 300  AT      the                      Z5 
0000020 310  JJ      transgenic               Z99 
0000020 320  NN2     animals                  L2mfn S5+c O2c 
0000020 321  .       .                        
0000021 001  -----   -----                    
0000022 010  JJ      Future                   T1.1.3 
0000022 020  NN2     studies                  P1 X2.4 H2 Q1.2 C1 
0000022 030  VM      will                     T1.1.3 
0000022 040  VVI     include                  A1.8+ 
0000022 050  JJ      developing               A2.1+ T2+ A5.1+/A2.1 N3.2+/A2.1 H1 A9+ C1 
0000022 060  JJ      similar                  A6.1+ 
0000022 070  NN2     defenses                 S8+ G3 G2.1c Q2.2 K5.1 S7.3+ P1 
0000022 080  II      against                  Z5 
0000022 090  JJ      other                    A6.1- 
0000022 100  NN2     pathogens                Z99 
0000022 110  CST     that                     Z8 Z5 
0000022 120  VV0     affect                   A2.1+ A5.4-/A8 
0000022 130  NN1     dairy                    F4/L2[i19.2.1 F4 
0000022 140  NN2     cattle                   F4/L2[i19.2.2 L2mfn 
0000022 141  ,       ,                        
0000022 150  II31    as                       N5++[i20.2.1 Z5 
0000022 160  II32    well                     N5++[i20.2.2 
0000022 170  II33    as                       Z5 
0000022 180  VVG     gauging                  X6+ X2.4 
0000022 190  AT      the                      Z5 
0000022 200  NN1     milk                     F2 O1.2 
0000022 201  GE      's                       Z5 
0000022 210  NN1     ability                  X9.1+ 
0000022 220  TO      to                       Z5 
0000022 230  RR      effectively              A5.4+ X9.2+ 
0000022 240  VVI     produce                  A2.2 A1.1.1 A10+ K4 K3 Q4.3 F4 
0000022 250  JJ      common                   A6.2+ N5++ S5+ O4.2- 
0000022 260  NN1     dairy                    F1[i21.2.1 F4 
0000022 270  NN2     products                 F1[i21.2.2 O2 A1.1.1 A2.2 N2% 
0000022 271  ,       ,                        
0000022 280  II21    such                     Z5[i22.2.1 
0000022 290  II22    as                       Z5[i22.2.2 Z5 
0000022 300  NN1     cheese                   F1 
0000022 310  CC      and                      Z5 
0000022 320  NN1     yogurt                   F1 
0000022 321  .       .                        
0000025 001  NULL    **8;7;text               
